eXoZymes, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $54.1M
- Price
- $5.81
- % Change (Daily % change from the live per-ticker quote feed.)
- +4.87%
- Volume
- 21.5K
About
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Quick stats
Shares outstanding9.3M
Computed float3.3M
Float / shares35.0%
Cash runway (months)7
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0002010788
Websitehttps://exozymes.com
AI Summary
AI-generated1/20
standardbullishpartnership
eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT
eXoZymes has entered into a partnership with Curia Global to initiate commercial-scale manufacturing of its NCT product.
The program is expected to begin in Q4 2026 and establish a technical roadmap for larger-scale production in 2027.
Curia will scale the process at its facilities in León, Spain, and Rozzano, Italy, and perform cross-validation of eXoZymes' proprietary manufacturing processes.